Literature DB >> 12406337

Characterization of mouse profilaggrin: evidence for nuclear engulfment and translocation of the profilaggrin B-domain during epidermal differentiation.

Dan Zhang1, Seetha Karunaratne, Monica Kessler, Donna Mahony, Joseph A Rothnagel.   

Abstract

Filaggrin is a keratin filament associated protein that is expressed in granular layer keratinocytes and derived by sequential proteolysis from a polyprotein precursor termed profilaggrin. Depending on the species, each profilaggrin molecule contains between 10 and 20 filaggrin subunits organized as tandem repeats with a calcium-binding domain at the N- terminal end. We now report the characterization of the complete mouse gene. The structural organization of the mouse gene is identical to the human profilaggrin gene and consists of three exons with a 4 kb intron within the 5' noncoding region and a 1.7 kb intron separating the sequences encoding the calcium-binding EF-hand motifs. A processed pseudogene was found embedded within the second intron. The third and largest exon encodes the second EF-hand, a basic domain (designated the B-domain) followed by 12 filaggrin repeats and a unique C-terminal tail domain. A polyclonal antibody raised against the conceptually translated sequence of the B-domain specifically stained keratohyalin granules and colocalized with a filaggrin antibody in granular layer cells. In upper granular layer cells, B-domain containing keratohyalin granules were in close apposition to the nucleus and, in some cells, appeared to be completely engulfed by the nucleus. In transition layer cells, B-domain staining was evident in the nucleus whereas filaggrin staining remained cytoplasmic. Nuclear staining of the B-domain was also observed in primary mouse keratinocytes induced to differentiate. This study has also revealed significant sequence homology between the mouse and human promoter sequences and in the calcium-binding domain but the remainder of the protein-coding region shows substantial divergence.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12406337     DOI: 10.1046/j.1523-1747.2002.00133.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  6 in total

1.  Deimination of human filaggrin-2 promotes its proteolysis by calpain 1.

Authors:  Chiung-Yueh Hsu; Julie Henry; Anne-Aurélie Raymond; Marie-Claire Méchin; Valérie Pendaries; Dany Nassar; Britta Hansmann; Stéfana Balica; Odile Burlet-Schiltz; Anne-Marie Schmitt; Hidenari Takahara; Carle Paul; Guy Serre; Michel Simon
Journal:  J Biol Chem       Date:  2011-04-29       Impact factor: 5.157

2.  Filaggrin in the frontline: role in skin barrier function and disease.

Authors:  Aileen Sandilands; Calum Sutherland; Alan D Irvine; W H Irwin McLean
Journal:  J Cell Sci       Date:  2009-05-01       Impact factor: 5.285

3.  Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect.

Authors:  Sara J Brown; Karin Kroboth; Aileen Sandilands; Linda E Campbell; Elizabeth Pohler; Sanja Kezic; Heather J Cordell; W H Irwin McLean; Alan D Irvine
Journal:  J Invest Dermatol       Date:  2011-11-10       Impact factor: 8.551

4.  Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1.

Authors:  Karin List; Roman Szabo; Philip W Wertz; Julie Segre; Christian C Haudenschild; Soo-Youl Kim; Thomas H Bugge
Journal:  J Cell Biol       Date:  2003-11-24       Impact factor: 10.539

5.  Differences in Behavior between Normal and Atopic Keratinocytes in Culture: Pilot Studies.

Authors:  Rosanna Marsella; Kim Ahrens; Rachel Wilkes
Journal:  Vet Sci       Date:  2022-06-30

6.  A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming.

Authors:  Padraic G Fallon; Takashi Sasaki; Aileen Sandilands; Linda E Campbell; Sean P Saunders; Niamh E Mangan; John J Callanan; Hiroshi Kawasaki; Aiko Shiohama; Akiharu Kubo; John P Sundberg; Richard B Presland; Philip Fleckman; Nobuyoshi Shimizu; Jun Kudoh; Alan D Irvine; Masayuki Amagai; W H Irwin McLean
Journal:  Nat Genet       Date:  2009-04-06       Impact factor: 38.330

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.